Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2003
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474884A1 Stimulation of cpt-1 as a means to reduce weight
08/14/2003CA2474431A1 Method of treating and preventing bone loss
08/14/2003CA2474424A1 Salts of valsartan
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2474016A1 A combination for treating cold and cough
08/14/2003CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003CA2473499A1 Minrs as modifiers of insulin receptor signaling and methods of use
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/14/2003CA2471586A1 Tumor necrosis factor combined with interferon in demyelinating diseases
08/14/2003CA2471207A1 Method of inhibiting pathogenicity of infectious agents
08/14/2003CA2469748A1 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003CA2466251A1 Therapeutic use of aziridino compounds
08/13/2003EP1335202A1 Method for screening compounds being modulators of neuromediators
08/13/2003EP1335023A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
08/13/2003EP1334725A2 Estroprogestative contraceptive composition
08/13/2003EP1334722A1 Granular drug preparations containing branched amino acids and process for producing the same
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334193A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/13/2003EP1334192A2 Cystoskeleton-associated proteins
08/13/2003EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/13/2003EP1334180A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
08/13/2003EP1334178A1 Slo2 and slo4, novel potassium channel proteins from human brain
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP1334106A2 Novel imidazole derivatives, production method thereof and use thereof
08/13/2003EP1333887A2 Combination therapy comprising anti-diabetic and anticonvulsant agents
08/13/2003EP1333880A1 Transdermal drug delivery devices having coated microprotrusions
08/13/2003EP1333859A2 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
08/13/2003EP1333856A1 Modulating angiogenesis
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1333845A1 Treatment of t cell disorders
08/13/2003EP1333842A2 Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
08/13/2003EP1333839A1 Method for the treatment of inflammation
08/13/2003EP1333837A1 Improved treatment
08/13/2003EP1333832A1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
08/13/2003EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids
08/13/2003EP1333829A1 Treatment of sexual dysfunction using bombesin antagonists
08/13/2003EP1333828A2 Prevention of development of dyskinesias
08/13/2003EP1333824A2 Treatment of sexual dysfunction
08/13/2003EP1333823A1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333811A1 Liposomal formulation of mitoxantrone
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1220656B1 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase
08/13/2003EP1143981A4 Treatment and prevention of hiv and other viral infections
08/13/2003EP1143942B1 Use of gaba-b receptor ligands for the manufacture of medicaments for the treatment of neurodegenerative diseases
08/13/2003EP1098665B9 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
08/13/2003EP1066060B1 Mesenchymal stem cells as immunosuppressants
08/13/2003EP0989859B1 Cns neuroregenerative compositions and methods of use
08/13/2003EP0667959B1 Methods for identifying inhibitors of the production of beta-amyloid peptide
08/13/2003CN1436241A Sphingosine kinase and uses thereof
08/13/2003CN1436233A Methods and compositions based on VEGF antisense oligonucleotides
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436085A Method for treating pain by peripheral administration of neurotoxin
08/13/2003CN1436080A Use of cyclic-GMP-specific phosphodiesterase inhibitor for treating parkinson's disease
08/13/2003CN1436076A Method of treating cardiovascular disease
08/13/2003CN1435176A Triclabendazole-contg. preparation based on surfactant
08/13/2003CN1117751C Antiviral nucleoside analogues
08/13/2003CN1117585C Nisin in combination with glycerol monolaurate active against helicobacterium
08/13/2003CN1117567C Paroxetine controlled release compositions
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/13/2003CN1117562C Compositions and method for controlling smoking
08/12/2003US6605753 Transgenic mouse with increased insulin sensitivity; resistance to weight gain when fed a high fat, high carbohydrate diet
08/12/2003US6605751 Silver-containing compositions, devices and methods for making
08/12/2003US6605702 Protein for use in the treatment of inflammatory defects and asthma
08/12/2003US6605641 20-HETE antagonists and agonists
08/12/2003US6605612 Cardioprotective phosohonates and malonates
08/12/2003US6605605 Estrogenic substances combined with cruciferous indole compounds
08/12/2003US6605603 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
08/12/2003US6605591 Treatment of subnormal bone mineral density
08/12/2003US6605456 Nucleic acids encoding IKR-2, a protein kinase related to the I kappa B kinases
08/12/2003US6605298 Drug delivery
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6604698 Forming a dispersion of solid particles of a milled substrate in a fluid carrier comprising providing large size milling media and small size milling media, a conglomerate of solid comprising a substrate to be milled, milling, separating
08/08/2003CA2417305A1 Method of affecting sleep & sleep-related behaviours
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003065006A2 Methods and compositions for treating cancer
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003064456A1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c)
08/07/2003WO2003064455A2 Macrocyclic peptides active against the hepatitis c virus
08/07/2003WO2003064451A2 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
08/07/2003WO2003064448A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
08/07/2003WO2003064423A1 Aza-arylpiperazines
08/07/2003WO2003064419A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/07/2003WO2003064418A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
08/07/2003WO2003064402A1 Treatment of male sexual dysfunction
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064383A2 Phosphorus-containing compounds & uses thereof
08/07/2003WO2003064376A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/07/2003WO2003063927A2 Compositions and methods to treat gastrointestinal disorders
08/07/2003WO2003063908A1 Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
08/07/2003WO2003063907A1 Drugs ameliorating circadian rhythum disorder
1 ... 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 ... 1151